Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) Invested Capital (2019 - 2025)

P3 Health Partners (PIII) has disclosed Invested Capital for 7 consecutive years, with $226.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Invested Capital fell 24.52% year-over-year to $226.4 million, compared with a TTM value of $226.4 million through Jun 2025, down 24.52%, and an annual FY2024 reading of $260.0 million, changed N/A over the prior year.
  • Invested Capital was $226.4 million for Q2 2025 at P3 Health Partners, down from $234.4 million in the prior quarter.
  • Across five years, Invested Capital topped out at $300.0 million in Q2 2024 and bottomed at -$272.9 million in Q4 2021.
  • Average Invested Capital over 5 years is $89.3 million, with a median of $109.8 million recorded in 2022.
  • The sharpest move saw Invested Capital crashed 125.48% in 2023, then surged 1172.14% in 2024.
  • Year by year, Invested Capital stood at -$272.9 million in 2021, then surged by 136.74% to $100.3 million in 2022, then skyrocketed by 195.38% to $296.2 million in 2023, then decreased by 12.22% to $260.0 million in 2024, then decreased by 12.92% to $226.4 million in 2025.
  • Business Quant data shows Invested Capital for PIII at $226.4 million in Q2 2025, $234.4 million in Q1 2025, and $260.0 million in Q4 2024.